
REGENXBIO Inc.
USD10.34
+0.02 (+0.19%)
CEO
Curran Simpson
IPO Date
2015-09-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$10.30
Prev. Close
$10.32
Day Low
$10.05
Day High
$10.49
52W Low
$5.46
52W High
$16.19
Market Cap
$0.53B
Volume
1.67M
REGENXBIO Presents Additional Positive Interim Data from Phase I/II Trial of RGX-121 for the Treatment of MPS II (Hunter Syndrome) at American Society of Gene and Cell Therapy's 24th Annual Meeting